Clinical and Vaccine Immunology · 2008 · 35 citations · 12 references
Life SciencesImmunologyMolecular BiologyAutoimmunityProteomicsRheumatologyAutoimmune DiseasesConnective Tissue DiseasesConnective Tissue DisordersProteomic BiomarkersSystemic Autoimmune DiseaseSystemic Lupus ErythematosusConnective Tissue Disease PathologyDisease Activity MeasurementDisease ProteomicsPlasma ProteomicsProteasome DysfunctionProteasome SystemSerum ProteomicsSystemic Lupus Erythematosus Associations
The associations of circulating 20S proteasomes (c20S) with clinical and serologic disease indices in patients with systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD) are unknown. We present the initial report that c20S levels are elevated in MCTD and correlate with clinically relevant changes in disease activity in SLE and MCTD.
12
The 1982 revised criteria for the classification of systemic lupus erythematosus
Eng M. Tan, Alan S. Cohen, James F. Fries et al. · Arthritis & Rheumatism · 1982 · 14.6K citations
Derivation of the sledai. A disease activity index for lupus patients
Claire Bombardier, Dafna D. Gladman, Murray B. Urowitz et al. · Arthritis & Rheumatism · 1992 · 4.6K citations
Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases.
Karl Egerer, Ulrike Kuckelkorn, Paul Rudolph et al. · PubMed · 2002 · 123 citations